| Trading Companies & Distributors Industry | Industrials Sector | Sang Tae Choi CEO | OTC PINK Exchange | 66979K103 CUSIP |
| US Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Nouveau Life Pharmaceuticals, Inc., initially incorporated as Hybrid Fuels, Inc., transitioned its corporate identity to better reflect its mission in May 2012. Now primarily focused on the burgeoning nutraceutical sector, this development stage company aims to innovate within the realm of natural health solutions. By offering an array of nutraceutical products, Nouveau Life Pharmaceuticals seeks to provide natural alternatives alongside traditional prescription drugs, answering the growing consumer demand for holistic and wellness-focused options. Based in Ft. Lauderdale, Florida, the company leverages its strategic location and resources to develop products that combine modern science with natural ingredients. As a subsidiary of EMG Marketing Solutions, Inc., Nouveau Life Pharmaceuticals is poised to capitalize on the extensive marketing and distribution channels available, facilitating the reach of its products to a broader market.
Nouveau Life Pharmaceuticals focuses on the formulation and development of nutraceutical products. These offerings aim to bridge the gap between pharmaceuticals and nutritional supplements, providing consumers with natural alternatives to traditional medicine. The company leverages cutting-edge research and development practices to create supplements that contribute to overall health and well-being.
In addition to its nutraceutical lines, Nouveau Life Pharmaceuticals explores the development of natural alternatives to prescription medications. This initiative addresses the growing consumer inclination towards organic and holistic remedies for common health issues, offering potential benefits without the extensive side effects often associated with pharmaceutical drugs.